structure of 5-Bromo-3-chloro-2-iodobenzonitrile

5-Bromo-3-chloro-2-iodobenzonitrile

CAS No.: 1000577-40-1
M. Wt: 342.35900
M. Fa: C7H2BrClIN
InChI Key: IBXCHLAUBNJQHQ-UHFFFAOYSA-N
Appearance: Solid

Names and Identifiers of 5-Bromo-3-chloro-2-iodobenzonitrile

CAS Number

1000577-40-1

MDL Number

MFCD09800800

IUPAC Name

5-bromo-3-chloro-2-iodobenzonitrile

InChI

InChI=1S/C7H2BrClIN/c8-5-1-4(3-11)7(10)6(9)2-5/h1-2H

InChIKey

IBXCHLAUBNJQHQ-UHFFFAOYSA-N

Canonical SMILES

N#CC1=CC(Br)=CC(Cl)=C1I

UNSPSC Code

12352100

Physical and chemical properties of 5-Bromo-3-chloro-2-iodobenzonitrile

Exact Mass

340.81000

LogP

3.57878

Molecular Formula

C7H2BrClIN

Molecular Weight

342.35900

PSA

23.79000

Safety Information of 5-Bromo-3-chloro-2-iodobenzonitrile

Pictograms

Signal Word

Warning

Safety Data Sheet

Supports customized editing of SDS information and downloading in PDF documents.

Applications of 5-Bromo-3-chloro-2-iodobenzonitrile

5-Bromo-3-chloro-2-iodobenzonitrile is utilized in various fields:

  • Synthetic Chemistry: As an intermediate in the synthesis of complex organic molecules.
  • Pharmaceuticals: Potentially as a building block for drug candidates targeting specific biological pathways.
  • Material Science: In the development of new materials with tailored properties due to its unique chemical structure.

Interaction Studies of 5-Bromo-3-chloro-2-iodobenzonitrile

Interaction studies involving 5-Bromo-3-chloro-2-iodobenzonitrile have focused on its ability to bind with specific molecular targets in biological systems. The presence of multiple halogens may facilitate interactions through halogen bonding, enhancing the compound's affinity for certain receptors or enzymes. These interactions are critical for understanding its potential therapeutic effects and guiding further drug development efforts.

Biological Activity of 5-Bromo-3-chloro-2-iodobenzonitrile

Research indicates that 5-Bromo-3-chloro-2-iodobenzonitrile exhibits biological activity, particularly in the context of medicinal chemistry. Its halogenated structure may enhance binding affinity to biological targets, making it a candidate for drug development. Studies have shown that compounds with similar structures can possess antiproliferative activity against various cancer cell lines, suggesting potential therapeutic applications.